Documents
A list of downloadable documents created during development.
Background information
-
Appendix A: matrix of stakeholders 99.13 KB
Follicular lymphoma - rituximab (review): EIA
Follicular lymphoma - rituximab (review): final appraisal determination
-
Follicular lymphoma - rituximab (review): consultee and commentator comments on the ACD
Follicular lymphoma - rituximab (review): appraisal consultation
-
Follicular lymphoma - rituximab (review): appraisal consultation
-
Follicular lymphoma - rituximab (review): evaluation report
-
Follicular lymphoma - rituximab (review): assessment report
-
Follicular lymphoma - rituximab (review): consultee and commentator comments on the assessment report
-
Follicular lymphoma - rituximab (review): Healthcare Improvement Scotland
-
Follicular lymphoma - rituximab (review): response to consultee and commentator comments on the assessment report
-
Follicular lymphoma - rituximab (review): non-manufacturer submission
-
Follicular lymphoma - rituximab (review): expert written personal statements